By Tobias Lengnan Dapam
National Agency for Food and Drug Administration and Control (NAFDAC), has partnered Global Standard 1 (GS1) to track and eliminate substandard products in the country.
Speaking yesterday while hosting representatives of GS1 at the headquarters of the agency in Abuja, the Director General of NAFDAC, Prof. Mojisola Adeyeye said, “the partnership will ensure that these regulated products are traceable with the aim of eliminating substandard and falsified medicines (SFs) in the supply chain, thus safeguarding the health of the population.
To this end, she added that the agency and GS1 will will on September 17, cohost the second African GS1 Healthcare conference in Lagos
Mojisola said the which end on September 19, will welcome more than 300 participants from 44 countries, including over 100 representatives from healthcare regulators.
“The agency is happy partnering a neutral, not-for-profit organisation that
develops and maintains global standards used to improve the efficiency, safety and visibility of supply chains. NAFDAC is co-hosting the conference as a continuum in fulfilling the Agency’s mandate that includes the control of distribution, sale and use (or supply chain) of medicines and medical products.
“The conference is supported by the World Bank, Global Fund, USAID and International Federation of Pharmaceutical Manufacturers (IFPMA).
“For this conference, health care regulators from across Africa will join international organisations, regional and global health care stakeholders and prominent experts to address global health policy aspects to prevent falsified medicines entering the supply chain through implementing traceability.”
She further said that the WHO recently estimated 1 in 10 medical products circulating in low and middle-income countries are either substandard or falsified, especially in Africa, that accounts for 42% of the detected cases worldwide.
“Addressing this situation may help prevent widespread loss of life in this continent, including an estimated 64 000-158 000 avoidable deaths from malaria alone. Furthermore, falsified medication has an economic impact and results in less trust in the healthcare system.
“The GS1 Healthcare conference in Lagos will provide a unique opportunity for healthcare stakeholders to discuss how to work together across Africa to achieve better traceability of pharmaceuticals and to improve patient safety. Delegates will also hear about WHO efforts to prevent substandard and falsified medical products entering the global market. Leading experts will showcase how GS1 standards help supply chain partners, including healthcare professionals, implementing traceability, making sure that the patient receives the right medication.